<DOC>
	<DOCNO>NCT00470366</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , cisplatin , ifosfamide , paclitaxel , work different way stop growth tumor cell , either kill cell stop divide . Giving one drug ( combination chemotherapy ) may kill tumor cell . Colony-stimulating factor , pegfilgrastim , may increase number immune cell find bone marrow peripheral blood may help immune system recover side effect chemotherapy . PURPOSE : This phase II trial study side effect well give combination chemotherapy together pegfilgrastim work treat patient previously untreated germ cell tumor .</brief_summary>
	<brief_title>Combination Chemotherapy Pegfilgrastim Treating Patients With Previously Untreated Germ Cell Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy chemotherapy comprise paclitaxel , ifosfamide , cisplatin combination pegfilgrastim patient previously untreated intermediate- poor-risk germ cell tumor . - Determine safety regimen patient . - Determine toxicity regimen patient . OUTLINE : Patients receive paclitaxel IV 120-180 minute day 1 2 , cisplatin IV 30 minute ifosfamide IV 120 minute day 1-5 , pegfilgrastim subcutaneously day 6 . Treatment repeat every 21 day 4 course absence disease progression unacceptable toxicity . Some patient may require surgery chemotherapy , viable non-teratomatous germ cell tumor find surgical specimen interval disease progression , patient may receive 1-2 course chemotherapy surgery . After completion study treatment , patient follow 28 day every 2 month 1 year . PROJECTED ACCRUAL : A total 55 patient accrue study .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<mesh_term>Teratoma</mesh_term>
	<mesh_term>Testicular Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Isophosphamide mustard</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Ifosfamide</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm germ cell tumor meet 1 follow criterion : Poor risk , define follow : Testis retroperitoneal primary site nonseminoma histology without visceral metastasis `` poorrisk '' marker , define follow : Pretreatment serum lactate dehydrogenase ( LDH ) &gt; 10 time upper limit normal ( ULN ) Pretreatment serum human chorionic gonadotropin ( HCG ) &gt; 50,000 IU/L Pretreatment serum alpha fetoprotein ( AFP ) &gt; 10,000 ng/mL Testis retroperitoneal primary site nonseminoma histology one nonpulmonary visceral metastasis , include follow ( regardless serum tumor marker value ) : Bone metastases Brain metastasis Hepatic metastases Any nonpulmonary metastasis ( i.e. , skin , spleen ) Mediastinal primary site nonseminoma histology regardless serum tumor marker level presence/absence visceral metastasis Modified intermediate risk , define follow : Testis retroperitoneal primary site nonseminoma histology nonpulmonary visceral metastasis , follow serum marker value : Pretreatment serum LDH 3.010 time ULN Pretreatment serum HCG 5,00050,000 IU/L Pretreatment serum AFP 1,00010,000 ng/mL Seminoma histology one nonpulmonary visceral metastasis , include follow ( regardless serum tumor marker value primary site ) : Bone metastases Brain metastasis Hepatic metastases Any nonpulmonary visceral metastasis ( i.e. , skin , spleen ) Previously untreated disease Measurable evaluable disease PATIENT CHARACTERISTICS : WBC ≥ 3,000/mm^3 Platelet count ≥ 100,000/mm^3 Creatinine normal creatinine clearance &gt; 50 mL/min ( unless renal dysfunction due tumor obstruct ureter ) AST ALT ≤ 3 time ULN Bilirubin ≤ 2.0 time ULN Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception No concurrent malignancy except nonmelanoma skin cancer No know HIV positivity No active infection PRIOR CONCURRENT THERAPY : Recovered prior surgery More 30 day since prior radiotherapy recover ( unless evidence progressive disease document ) No prior chemotherapy No concurrent cytotoxic therapy Concurrent radiotherapy surgery allow treatment brain metastasis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>stage II malignant testicular germ cell tumor</keyword>
	<keyword>stage III malignant testicular germ cell tumor</keyword>
	<keyword>testicular choriocarcinoma embryonal carcinoma</keyword>
	<keyword>testicular choriocarcinoma seminoma</keyword>
	<keyword>testicular choriocarcinoma teratoma</keyword>
	<keyword>testicular choriocarcinoma yolk sac tumor</keyword>
	<keyword>testicular choriocarcinoma</keyword>
	<keyword>testicular embryonal carcinoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma seminoma</keyword>
	<keyword>testicular embryonal carcinoma teratoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor seminoma</keyword>
	<keyword>testicular embryonal carcinoma yolk sac tumor</keyword>
	<keyword>testicular embryonal carcinoma</keyword>
	<keyword>testicular seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma seminoma</keyword>
	<keyword>testicular yolk sac tumor teratoma</keyword>
	<keyword>testicular yolk sac tumor</keyword>
	<keyword>stage I malignant testicular germ cell tumor</keyword>
	<keyword>adult central nervous system germ cell tumor</keyword>
	<keyword>ovarian choriocarcinoma</keyword>
	<keyword>ovarian dysgerminoma</keyword>
	<keyword>ovarian embryonal carcinoma</keyword>
	<keyword>ovarian yolk sac tumor</keyword>
	<keyword>ovarian immature teratoma</keyword>
	<keyword>ovarian mature teratoma</keyword>
	<keyword>ovarian monodermal highly specialized teratoma</keyword>
	<keyword>ovarian polyembryoma</keyword>
	<keyword>ovarian mixed germ cell tumor</keyword>
	<keyword>stage IV ovarian germ cell tumor</keyword>
	<keyword>stage IV extragonadal seminoma</keyword>
	<keyword>stage I extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage II extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage III extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>stage IV extragonadal non-seminomatous germ cell tumor</keyword>
	<keyword>adult teratoma</keyword>
	<keyword>testicular immature teratoma</keyword>
	<keyword>testicular mature teratoma</keyword>
	<keyword>stage IA ovarian germ cell tumor</keyword>
	<keyword>stage IB ovarian germ cell tumor</keyword>
	<keyword>stage IC ovarian germ cell tumor</keyword>
	<keyword>stage IIA ovarian germ cell tumor</keyword>
	<keyword>stage IIB ovarian germ cell tumor</keyword>
	<keyword>stage IIC ovarian germ cell tumor</keyword>
	<keyword>stage IIIA ovarian germ cell tumor</keyword>
	<keyword>stage IIIB ovarian germ cell tumor</keyword>
	<keyword>stage IIIC ovarian germ cell tumor</keyword>
</DOC>